Griet Jacobs

Griet Jacobs

Auto-generated profile, based on publicly available information

Griet Jacobs

Laboratory of Physiopharmacology, GENCOR, University of Antwerp, Antwerp, Belgium

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 July 2022 in European Heart Journal
Verified
Journal Article
Closed access
PDF file
FVFrone Vandewiele
Frone Vandewiele
APAndy Pironet
Andy Pironet
GJGriet Jacobs
Griet Jacobs
MKMiklos Kecskes
Miklos Kecskes
JWJörg Wegener
Jörg Wegener
RVRudi Vennekens
Rudi Vennekens
Cardiac arrhythmias are a major factor in the occurrence of morbidity and sudden death in patients with cardiovascular disease. Disturbances of Ca2+ homeostasis in the heart contribute to the initiation and maintenance of cardiac arrhythmias. Extrasystolic increases in intracellular Ca2+ lead to delayed afterdepolarizations and triggered activity, which can result in heart rhythm abnormalities. It is being suggested that the Ca2+-activated nonselective cation channel TRPM4 is involved in the aetiology of triggered activity, but the exact contribution and in vivo significance are still unclear. In vitro electrophysiological and calcium imaging technique as well as in vivo intracardiac and telemetric electrocardiogram measurements in physiological and pathophysiological conditions were performed. In two distinct Ca2+-dependent proarrhythmic models, freely moving Trpm4−/− mice displayed a reduced burden of cardiac arrhythmias. Looking further into the specific contribution of TRPM4 to the cellular mechanism of arrhythmias, TRPM4 was found to contribute to a long-lasting Ca2+ overload-induced background current, thereby regulating cell excitability in Ca2+ overload conditions. To expand these results, a compound screening revealed meclofenamate as a potent antagonist of TRPM4. In line with the findings from Trpm4−/− mice, 10 µM meclofenamate inhibited the Ca2+ overload-induced background current in ventricular cardiomyocytes and 15 mg/kg meclofenamate suppressed catecholaminergic polymorphic ventricular tachycardia-associated arrhythmias in a TRPM4-dependent manner. The presented data establish that TRPM4 represents a novel target in the prevention and treatment of Ca2+-dependent triggered arrhythmias. Proposed mechanism of the specific contribution of TRPM4 to the cellular mechanism of Ca2+-dependent triggered arrhythmias associated with, for example, acute ischaemia or catecholaminergic polymorphic ventricular tachycardia (CPVT). Typically for these conditions, aberrant Ca2+ release events induce a transient inward current (Iti) on top of a background current (Ibackground) in ventricular myocytes, which underlies delayed afterdepolarizations that trigger ectopic action potentials when the threshold potential is reached. The TRPM4 specifically contributes to the Ca2+ overload-induced background current that augments cellular excitability, and inhibition of TRPM4 with meclofenamate efficiently suppresses CPVT-associated arrhythmias in living mice. AP, action potential; CPVT, catecholaminergic polymorphic ventricular tachycardia; DAD, delayed afterdepolarization; Vm, membrane potential; Vthreshold, threshold potential.

1 August 2021 in Toxicology Letters
Verified
Journal Article
Closed access
MBMatthias Bosman
Matthias Bosman
KFKasper Favere
Kasper Favere
CNCédric Neutel
Cédric Neutel
GJGriet Jacobs
Griet Jacobs
GMGuido R.Y. De Meyer
Guido R.Y. De Meyer
PGPieter-Jan Guns
Pieter-Jan Guns

1 June 2021 in American Journal of Physiology-Heart and Circulatory Physiology
Verified
Journal Article
Closed access
PDF file
HSHadis Shakeri
Hadis Shakeri
JBJente R. A. Boen
Jente R. A. Boen
SMSofie De Moudt
Sofie De Moudt
JHJhana O. Hendrickx
Jhana O. Hendrickx
ALArthur J. A. Leloup
Arthur J. A. Leloup
VSVincent F. M. Segers
Vincent F. M. Segers
Endothelial cells (ECs) secrete different paracrine signals that modulate the function of adjacent cells; two examples of these paracrine signals are nitric oxide (NO) and neuregulin-1 (NRG1), a cardioprotective growth factor. Currently, it is undetermined whether one paracrine factor can compensate for the loss of another. Herein, we hypothesized that NRG1 can compensate for endothelial NO synthase (eNOS) deficiency. We characterized eNOS null and wild-type (WT) mice by cardiac ultrasound and histology and we determined circulating NRG1 levels. In a separate experiment, eight groups of mice were divided into four groups of eNOS null mice and WT mice; half of the mice received angiotensin II (ANG II) to induce a more severe phenotype. Mice were randomized to daily injections with NRG1 or vehicle for 28 days. eNOS deficiency increased NRG1 plasma levels, indicating that ECs increase their NRG1 expression when NO production is deleted. eNOS deficiency also increased blood pressure, lowered heart rate, induced cardiac fibrosis, and affected diastolic function. In eNOS null mice, ANG II administration not only increased cardiac fibrosis but also induced cardiac hypertrophy and renal fibrosis. NRG1 administration prevented cardiac and renal hypertrophy and fibrosis caused by ANG II infusion and eNOS deficiency. Moreover, Nrg1 expression in the myocardium is shown to be regulated by miR-134. This study indicates that administration of endothelium-derived NRG1 can compensate for eNOS deficiency in the heart and kidneys. NEW & NOTEWORTHY ECs compensate for eNOS deficiency by increasing the secretion of NRG1. NRG1 administration prevents cardiac and renal hypertrophy and fibrosis caused by ANG II infusion and eNOS deficiency. NRG1 expression is regulated by miR-134.

1 October 2022 in American Journal of Physiology-Heart and Circulatory Physiology
Verified
Journal Article
Closed access
PDF file
KFKasper Favere
Kasper Favere
JFJens Van Fraeyenhove
Jens Van Fraeyenhove
GJGriet Jacobs
Griet Jacobs
MBMatthias Bosman
Matthias Bosman
SESander Eens
Sander Eens
HHHein Heidbuchel
Hein Heidbuchel
Electrophysiology studies (EPS) allow in-depth evaluation of cardiac electrophysiology and -pathology. These techniques have been adapted to the murine setting for (translational) studies, mainly focusing on arrhythmogenesis. Despite the frequent application of EPS via the transjugular route, a thorough description of the technique is currently lacking. This article aims to function as a comprehensive guide, also elaborating (for the first time) on nonsurgical aspects such as catheter positioning, tracing artifacts, stimulation protocols, and reference values.
1